Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX · Real-Time Price · USD
0.5539
-0.0232 (-4.02%)
At close: Jun 30, 2026, 4:00 PM EDT
0.5500
-0.0039 (-0.70%)
After-hours: Jun 30, 2026, 7:42 PM EDT
Context Therapeutics Market Cap
Context Therapeutics has a market cap or net worth of $50.89 million as of June 30, 2026. Its market cap has decreased by -9.86% in one year.
Market Cap
50.89M
Enterprise Value
-2.30M
1-Year Change
-9.86%
Ranking
Category
Stock Price
$0.55
Market Cap Chart
Since the IPO on October 20, 2021, Context Therapeutics's market cap has decreased from $51.03M to $50.89M, a decrease of -0.27%. That is a compound annual growth rate of -0.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 50.89M | -62.32% |
| Dec 31, 2025 | 135.06M | 43.39% |
| Dec 31, 2024 | 94.19M | 422.07% |
| Dec 29, 2023 | 18.04M | 73.39% |
| Dec 30, 2022 | 10.41M | -75.50% |
| Dec 31, 2021 | 42.46M | -16.78% |
| Oct 20, 2021 | 51.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MiNK Therapeutics | 57.99M |
| Filana Therapeutics | 57.97M |
| Boundless Bio | 57.50M |
| Dogwood Therapeutics | 55.49M |
| Xilio Therapeutics | 54.14M |
| aTyr Pharma | 51.72M |
| Impact BioMedical | 50.78M |
| Instil Bio | 50.39M |